Meir Medical Center
Kfar Saba, Israel
Location status: Recruiting
NCT Number: NCT06612242
Tracheostomy is one of the most common procedures in the intensive care unit in patients who need prolonged invasive mechanical ventilation. There is controversy in the literature regarding the ideal timing for performing tracheostomy in critically ill patients. Early tracheostomy may be associated with a decrease in ventilation days and hospitalization. We would like to investigate whether in ventilated patients with Guillain Barre syndrome, early tracheostomy will be associated with decreased ventilation days, decreased mortality and shorter hospital and ICU length of stay.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Kfar Saba, Israel
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All patients aged 18--99 who were admitted to the general intensive care unit from January 2012 to September 2024 with a diagnosis of Guillain-Barre syndrome who required mechanical ventilation and underwent tracheostomy during ICU stay.
-
Exclusion criteria
Missing recoreded data
-
Early tracheostomy (less than 7 days from ventilation) in mechanically ventilated patients with Guiilain-Barre syndrome
Late tracheostomy (more than 7 days from ventilation) in mechanically ventilated patients with Guiilain-Barre syndrome
Time frame: 1 year from intubation
number of ventilation days
Contact information is provided by the study sponsor or research team.
Meir Medical Center
Other
Early vs. Late Tracheostomy in Patients With Guillain -Barre Syndrome: Comparison of Clinical Outcomes- a Retrospective Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01306578
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Al Mansurah, Dakahlia Governorate, Egypt
View Trial DetailsNCT06994442
Agnosia, Analgesics, Opioid
Little Rock, Arkansas, United States
View Trial DetailsNCT07212595
Acute Kidney Injury, Female Urogenital Diseases
Cincinnati, Ohio, United States
View Trial DetailsNCT07716787
Acute Brain Injury, Brain Diseases
Dongying, Shandong, China
View Trial Details